TRANDATE
What it isCombined alpha-1 and non-selective beta blocker; hypertensive emergency and hypertension in pregnancy.
Why this oneIV titratability plus a pregnancy safety record make it a standard parenteral option in preeclampsia.
What limits itOrthostatic hypotension, and the beta blockade limits it in asthma. Hepatotoxicity is rare but reported.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypertension | adult | 100 mg BID | 200-400 mg BID | 1,200-2,400 mg/day (severe hypertension) |
Titration After 2-3 days, may titrate in 100 mg BID increments every 2-3 days (increments not to exceed 200 mg BID)
Renal Undefined
Hepatic Undefined
Pregnancy Pregnancy Category C; use only if potential benefit justifies potential fetal risk
Lactation Undefined
NO BOXED WARNINGS
Principal riskOrthostatic hypotension; the preferred agent in pregnancy
Cost, est. cash$5–$150/month
Generic entry1998
Legacy pregnancy categoryC
Defining liabilityBradycardia, hypotension and bronchospasm; overdose may cause conduction block or cardiogenic shock.

Open Labetalol in the interactive console ↗

